Recipient Organization
Insect Biotechnology, Inc.
(N/A)
Chapel Hill,NC 27515
Performing Department
(N/A)
Non Technical Summary
Insects pose several challenges to mankind. They consume the food crops that we grow, they transmit diseases to plants, man and animals, and cause infrastructure damage and destruction. Current methods to control insects are largely based on the use of toxic chemicals, principally neurotoxins, which also pose health risks to the users, consumers, and other nontarget organisms. There are numerous examples of safer, naturally occurring biocompatible materials that could be utilized to control insect populations if the material could be applied in such a manner that it was taken up by the target insect and reached its site of action. The technology developed in this project will facilitate the translocation of new biocompatible insecticidal agents (peptides, proteins, or nucleic acids) into the target insect to provide control of insect populations while reducing the risk associated with nontarget exosure. The purpose of this project is to prepare derivatives of Trypsin
Modulating Oostatic Factor (TMOF) to enhance its transport across the gut into the hemolymph (blood) of tobacco budworm (Heliothis virescens) and evaluate the potential effectiveness of TMOF as a safer, new insect control technology for application to an agriculturally significant insect pest.
Animal Health Component
100%
Research Effort Categories
Basic
(N/A)
Applied
100%
Developmental
(N/A)
Goals / Objectives
The tasks to be completed in Phase I are the following: Task 1, Synthesize TMOF-RO(ethyleneglycol).sub.7-O-hexane and -hexanoic acid conjugated polymers (TMOF-MCP); Task 2, Demonstrate that our current ELISA for native TMOF will also detect TMOFK (TMOF with an added carboxy terminal lysine residue) and TMOF-MCP formulated with yeast in meal pads and in the feces and the hemolymph of last stadium tobacco budworms, Heliothis virescens; Task 3, Determine the 24 h stability of TMOFK and TMOF-MCP in insect meal pads; Task 4, Feed fifth stadium larvae ad libitum meal pads containing TMOFK and TMOF-MCP and develop a washing protocol that will remove both TMOFK and TMOF-MCP from the external cuticle surface; Task 5, Feed fifth stadium larvae ad libitum meal pads containing TMOFK or TMOF-MCP, wash the larvae, obtain hemolymph and feces, and measure TMOF levels in each over a 24 h period; Task 6, Apply TMOFK and TMOF-MCP topically and determine the levels of each in hemolymph
over a 24 h period; Task 7, Feed TMOFK and TMOF-MCP to budworm neonates and determine the dose for 50% inhibition of gut protease activity and growth; and the median lethal dose for both compounds; Task 8, Evaluate results and commercial potential; and Task 9, Prepare final report.
Project Methods
Bt is the first successful example of the use of a protein for the control of agricultural insect pests. Many polypeptide hormones and insect-specific toxins have been identified as alternative protein insecticides to that of Bt. However, the limiting factors in their use are that they are digested when eaten and they do not act on the gut wall like Bt. Insect Biotechnology Inc. (IBI) has licensed from North Carolina State University (NCSU), a novel protein delivery system for insects using methyl(ethyleneglycol).sub.7-O-hexanoic acid conjugated polymers. Preliminary studies conducted at NCSU with an insulin-polymer developed as the first oral insulin, suggests that these polymers also work in the delivery of proteins into insect hemolymph. In this proposal we will synthesize TMOF-RO(ethyleneglycol).sub.7-O-hexane and -hexanoic acid conjugated polymers. TMOF (trypsin modulating oostatic factor) is an insect peptide hormone that has been exclusively commercialized by IBI
for the control of mosquito larvae but which also has activity against the tobacco budworm. Its mode of action is the inhibition of digestive enzyme biosynthesis and the cessation of feeding by binding to receptors on the hemolymph side of the gut ventricular epithelium. Feasibility will be demonstrated when we can show enhanced accumulation in the hemolymph and disruption of development. If successful, our discoveries will have high commercial value not just for the delivery of TMOF but as an enabling technology for most companies that are developing insecticides. One goal of IBI will be to license our technology or co-develop other applications for insect control, which will greatly broaden the commercial significance of this USDA SBIR proposal.